INTERCUREINTERCUREINTERCURE

INTERCURE

585.7ILAD
−3.5−0.59%
At close at Jan 2, 15:24 UTC
ILA
No trades
See on Supercharts

INCR fundamentals

Key facts

Market capitalization‪269.65 M‬ILS
Founded1994
CEOAlexander Rabinovitch
About

InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies in the Biomed Sector and Investments in the Medical Cannabis Sector segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.

Ownership
‪‪45.77 M‬‬
Free Float shares
‪‪25.75 M‬‬ (56.28%)
Closely held shares
‪‪20.01 M‬‬ (43.72%)
Free Float shares
‪‪25.75 M‬‬ (56.28%)
Closely held shares
‪‪20.01 M‬‬ (43.72%)
Capital structure
No data available
There's currently no data to show about this capital structure.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪269.65 M‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24

Growth and Profitability

Company’s recent performance and margins

Performance
Revenue
Net income
Net margin %
Revenue to profit conversion
No data available
There's currently no revenue data to show for the selected period.

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Cannabis
By country
Period: 2023
Israel

Dividends

Dividend yield, history and sustainability

INCR does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
Assets
Liabilities